2021
DOI: 10.3389/fmicb.2021.736449
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin 16 Enhances the Host Susceptibility to Influenza A Virus Infection

Abstract: Influenza A virus (IAV) is a major respiratory pathogen that causes seasonal and pandemic flu, being a threat to global health. Various viral and cellular factors have been characterized to support or limit IAV infection. Interleukin 16 (IL16) has been known as one of the blood signature biomarkers discriminating systemic inflammation due to viral infection vs. other etiologies. Here, we report that the level of IL16 was elevated in the serum samples, lung homogenates, and bronchoalveolar lavage fluid of IAV-i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
5
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 53 publications
1
5
0
Order By: Relevance
“…To do this we injected the hens with LPS, a well-known stimulator of the immune system ( Simpson and Trent, 2019 ), and compared the response to five established LPS-induced cytokines. In agreement with previous reports ( Erickson and Banks, 2011 ; Magrini et al, 2016 ; Jia et al, 2021 ), stimulation by LPS increased the expression significantly in the already established LPS-related cytokines and Pentraxin 3 ( Figure 1D ). Taken together, the significant correlation between duplicates within an array and the expected response to LPS indicate a specific recognition of the antibodies against their corresponding targets.…”
Section: Resultssupporting
confidence: 93%
“…To do this we injected the hens with LPS, a well-known stimulator of the immune system ( Simpson and Trent, 2019 ), and compared the response to five established LPS-induced cytokines. In agreement with previous reports ( Erickson and Banks, 2011 ; Magrini et al, 2016 ; Jia et al, 2021 ), stimulation by LPS increased the expression significantly in the already established LPS-related cytokines and Pentraxin 3 ( Figure 1D ). Taken together, the significant correlation between duplicates within an array and the expected response to LPS indicate a specific recognition of the antibodies against their corresponding targets.…”
Section: Resultssupporting
confidence: 93%
“…IL-16 significantly contributes to pathologies associated with inflammation, like inflammatory bowel disease [ 43 ]. Early studies demonstrate IL-16 functions in inhibition of the replication of the human immunodeficiency virus, and in enhancing the host susceptibility to influenza A virus infection [ 44 , 45 , 46 ].…”
Section: Resultsmentioning
confidence: 99%
“…Regarding IL-16, this is the first report of a recognition of the viral E protein by this cytokine, which has known functions as a chemoattractant and activator of CD4 + T-cells. IL-16 is included in a four-biomarker blood signature that discriminates host systemic inflammation caused by a viral infection from other etiologies [ 46 ]. It is noteworthy that a significant increase in the levels of IL-16 is observed in the serum and cerebrospinal fluid of patients with COVID-19 [ 63 ].…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, IL16 has been extensively studied for its ability to inhibit human immunodeficiency virus (HIV) replication, partly by suppressing mRNA expression (Baier et al 1995; Zhou et al 1997; Idziorek et al 1998). Additionally, but in contrast to its HIV-suppressive properties, IL16 can enhance the replication of influenza A virus (IAV) and facilitate its infection of hosts, potentially through its repression of type I interferon beta and interferon-stimulated genes (Jia et al 2021). IL16 can also contribute to the establishment of lifelong gamma herpesvirus infection (Liu et al 2020).…”
Section: Discussionmentioning
confidence: 99%